middle.news
Atomo Diagnostics Surges 121% Revenue, Expands Global Test Portfolio
10:12am on Wednesday 28th of January, 2026 AEDT
•
Healthcare
Read Story
Atomo Diagnostics Surges 121% Revenue, Expands Global Test Portfolio
10:12am on Wednesday 28th of January, 2026 AEDT
Key Points
Revenue jumps 121% QoQ to $1.5 million
Secures $500k HIV Self-Test order for Africa funded by Global Fund
Exclusive global license signed for novel liver function test targeting drug-induced liver injury
Operational expansion with increased blister production capacity in Sydney
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ATOMO DIAGNOSTICS (ASX:AT1)
OPEN ARTICLE